HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Gualtiero Palareti Selected Research

fibrin fragment D (D-dimer)

5/2015D-Dimer Testing in Patients With a First Unprovoked Venous Thromboembolism.
4/2015D-dimer for the diagnosis of upper extremity deep and superficial venous thrombosis.
2/2015How D-dimer assay can be useful in deciding the duration of anticoagulation after venous thromboembolism: a review.
10/2014Clinical decision rules and D-Dimer in venous thromboembolism: current controversies and future research priorities.
8/2014D-dimer, FVIII and thrombotic burden in the acute phase of deep vein thrombosis in relation to the risk of post-thrombotic syndrome.
7/2014D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study.
4/2014Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study.
4/2013Age and gender specific cut-off values to improve the performance of D-dimer assays to predict the risk of venous thromboembolism recurrence.
4/2013Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences.
10/2012Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Gualtiero Palareti Research Topics

Disease

44Venous Thromboembolism
11/2015 - 01/2002
23Venous Thrombosis (Deep-Vein Thrombosis)
11/2015 - 09/2002
12Hemorrhage
11/2015 - 07/2007
11Thrombosis (Thrombus)
04/2015 - 06/2003
10Thrombophilia
08/2012 - 05/2003
9Neoplasms (Cancer)
09/2012 - 08/2003
7Pulmonary Embolism
03/2013 - 10/2006
6Stroke (Strokes)
01/2015 - 07/2007
5Atrial Fibrillation
04/2014 - 08/2009
3Acute Coronary Syndrome
12/2011 - 08/2009
3Multiple Myeloma
06/2010 - 09/2002
3Protein S Deficiency (Deficiency, Protein S)
09/2004 - 08/2003
2Intracranial Hemorrhages (Intracranial Hemorrhage)
03/2014 - 06/2008
2Thromboembolism
02/2014 - 10/2006
2Activated Protein C Resistance (APC Resistance)
03/2005 - 06/2003
2Protein C Deficiency
09/2004 - 08/2003
1Postthrombotic Syndrome
02/2015
1Renal Insufficiency (Renal Failure)
01/2015
1Varicose Veins (Varicose Vein)
02/2014
1Homocystinuria
01/2013
1Hyperhomocysteinemia
01/2013
1Patent Foramen Ovale
11/2012
1Spontaneous Abortion (Miscarriage)
03/2012
1Pulmonary Hypertension (Ayerza Syndrome)
02/2012
1Budd-Chiari Syndrome (Budd Chiari Syndrome)
02/2012
1Thrombocytopenia (Thrombopenia)
08/2010
1Peripheral Nervous System Diseases (PNS Diseases)
11/2009
1Spinal Cord Diseases
11/2009
1Spinal Cord Injuries (Spinal Cord Injury)
11/2009
1Atrophy
02/2008
1Embolism (Embolus)
07/2007
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
05/2004
1Reperfusion Injury
03/2004
1Inflammation
03/2004
1Pancreatitis
03/2003

Drug/Important Bio-Agent (IBA)

35fibrin fragment D (D-dimer)IBA
05/2015 - 01/2002
13Vitamin KFDA Link
01/2015 - 10/2006
10factor V LeidenIBA
03/2013 - 06/2003
5Warfarin (Coumadin)FDA LinkGeneric
04/2014 - 07/2003
5Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
02/2014 - 11/2009
5Prothrombin (Factor II)IBA
03/2013 - 02/2002
5Fumigant 93 (D-D)IBA
01/2010 - 05/2005
4AnticoagulantsIBA
04/2014 - 02/2008
4Protein CIBA
09/2005 - 04/2004
3Heparin (Liquaemin)FDA LinkGeneric
09/2012 - 02/2002
3Dexamethasone (Maxidex)FDA LinkGeneric
06/2010 - 09/2002
3Thalidomide (Thalomid)FDA Link
06/2010 - 09/2002
3Factor VIII (Coagulation Factor VIII)IBA
01/2008 - 11/2004
3Antiphospholipid AntibodiesIBA
12/2007 - 08/2003
2Factor Xa (Coagulation Factor Xa)IBA
04/2014 - 04/2013
2Enoxaparin (Lovenox)FDA LinkGeneric
01/2012 - 02/2010
2Oral ContraceptivesIBA
11/2004 - 04/2004
1glucuronyl glucosamine glycan sulfate (Vessel)IBA
11/2015
1CreatinineIBA
01/2015
1ThrombinFDA Link
04/2014
1parnaparinIBA
02/2014
1FluxumIBA
02/2014
1rivaroxabanIBA
04/2013
1Vitamin B Complex (B Vitamins)IBA
01/2013
1Betaine (C.B.B.)FDA Link
01/2013
1Factor V (Coagulation Factor V)IBA
11/2012
1Carboxypeptidase U (TAFI)IBA
08/2012
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2012
1HormonesIBA
10/2010
1AntibodiesIBA
08/2010
1snake venom protein C activatorIBA
08/2010
1fondaparinux (Arixtra)FDA Link
02/2010
1recombinant FVIIa (rFVIIa)IBA
06/2008
1prothrombin complex concentrates (PPSB)IBA
06/2008
12,5-dichloro-4-bromophenol (B 2)IBA
07/2007
1Matrix MetalloproteinasesIBA
03/2004
1Aprotinin (Trasylol)FDA Link
03/2004
1Fibrinogen (Factor I)FDA Link
05/2003
1C-Reactive ProteinIBA
03/2003
1Antithrombin IIIIBA
03/2003
1Snake Venoms (Snake Venom)IBA
02/2002

Therapy/Procedure

2Compression Stockings
11/2015 - 02/2015
2Stents
12/2011 - 05/2011
2Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
12/2011 - 05/2011
2Stem Cell Transplantation
06/2010 - 07/2004
2Liver Transplantation
03/2004 - 06/2003
1Bariatric Surgery
12/2009
1Vena Cava Filters (Inferior Vena Cava Filter)
02/2008
1Autologous Transplantation
07/2004
1Transplants (Transplant)
06/2003
1Contraception (Birth Control)
05/2003